AngioDesign tailoring next-generation ACE inhibitors

Mario Ehlers, the chairman and founder of Angio-Design (UK) speaks to Informa senior editor and writer Sten Stovall during the BIO-Europe Spring® partnering conference in Stockholm, Sweden about the drug discovery group's use of structure-guided and computer-aided therapy design to proven disease targets and why the startup is focused on developing next-generation ACE inhibitors.

Interviewer: Sten Stovall – Senior Editor, Pharma Intelligence, In Vivo/Pink Sheet/Scrip
Interviewee: Mario Ehlers – Chairman of the Board and Founder, AngioDesign (UK) Ltd.